Outcomes of patients with cancer infected with SARS-CoV-2: results from the Ion Chiricuţă Oncology Institute series

•This is the first comprehensive study addressing the impact of COVID-19 in a large cohort of cancer patients in Romania.•Oncological patients had a higher death rate after COVID-19 infection in comparison with the general population.•Decreased PS was the prominent prognostic factor correlated with worse outcomes and death in multiple multivariate analysis.